COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 18 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $169,000 | – | 10,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 563,030 | $11,942,000 | 13.95% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 530,104 | $11,243,000 | 2.16% |
| FRIESS ASSOCIATES LLC | 235,092 | $4,986,000 | 1.88% |
| Weil Company, Inc. | 30,468 | $646,000 | 0.33% |
| VILLERE ST DENIS J & CO LLC | 247,250 | $5,244,000 | 0.28% |
| ACT CAPITAL MANAGEMENT, LLC | 7,500 | $160,000 | 0.08% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 64,634 | $1,371,000 | 0.07% |
| FNY Investment Advisers, LLC | 4,000 | $84,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 597 | $13,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 20,800 | $441,000 | 0.00% |